# Acrivon Therapeutics, Inc. (ACRV)

ACRV hits new 52-week high driven by strong social sentiment and upcoming trial catalysts. Increased engagements and mentions signal growing investor interest.

### About Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. is a biotechnology company focused on precision oncology.  
Acrivon Therapeutics, Inc. uses the ticker $ACRV for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Acrivon Therapeutics, Inc. (ACRV) trading volume is up 301.97% from the previous month.

### Price: $1.60
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$acrv/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$acrv/time-series/close.tsv)  
The price of ACRV has reached a new 52-week and all-time high, driven by strong social sentiment, increased engagements, and mentions of new catalysts for upcoming trials.  

24-Hour: 1.91%
7-Day: -2.4%
30-Day: -17.68%

1-Year High: $3 on 2026-01-06  
1-Year Low: $1.20 on 2025-06-20  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$acrv/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$acrv/time-series/alt_rank.tsv)  
Acrivon Therapeutics, Inc. (ACRV) is currently AltRank #1,847 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +1,903  
1-Year High: [-----] on 2026-02-11  
1-Year Low: [---] on 2026-01-25  
  
  
### Galaxy Score: [--]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$acrv/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$acrv/time-series/galaxy_score.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] +3  
[--] Month: [--] +41  
[--] Months: [--] +16  
[--] Year: [--] +24  
1-Year High: [--] on 2026-02-05  
1-Year Low: [--] on 2026-02-04  
  
  
### Engagements: [--] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$acrv/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$acrv/time-series/interactions.tsv)  
Current Value: [--]  
Daily Average: [-----]  
[--] Week: [------] -23%  
[--] Month: [------] -42%  
[--] Months: [-------] +41%  
[--] Year: [---------] +97%  
1-Year High: [-------] on 2025-09-08  
1-Year Low: [--] on 2025-11-02  

Engagements by network (24h):
News: [--]
TikTok: [--]
Reddit: [--]
YouTube: [--]
X: [---]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$acrv/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$acrv/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] -3.80%  
1-Year High: [---] on 2025-09-08  
1-Year Low: [--] on 2025-10-11  

Mentions by network (24h):
News: [--]
TikTok: [--]
Reddit: [--]
YouTube: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$acrv/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$acrv/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Acrivon Therapeutics, Inc. (ACRV) in the last [--] hours which is down 2.40% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] -5%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-02-26  
  
  
### Sentiment: 94%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$acrv/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$acrv/time-series/sentiment.tsv)  
Current Value: 94%  
Daily Average: 87%  
[--] Week: 100% no change  
[--] Month: 92% +7%  
[--] Months: 92% -8%  
[--] Year: 92% -8%  
1-Year High: 100% on 2025-02-15  
1-Year Low: 20% on 2025-06-22  

Most Supportive Themes:
- High Sentiment: (86%) The sentiment surrounding Acrivon Therapeutics, Inc. is overwhelmingly positive, indicating strong approval from the social community.
- Increased Engagements: (119%) There has been a significant surge in social engagements, showing a heightened level of interest and interaction with Acrivon Therapeutics, Inc. content.
  
Most Critical Themes:
- Decreased Mentions: (53%) A notable drop in mentions suggests a potential decrease in the overall conversation volume about Acrivon Therapeutics, Inc. on social media.
- Lowered Social Dominance: (0.0046%) The social dominance of Acrivon Therapeutics, Inc. has decreased, indicating a smaller share of the overall social media conversation.
  
  
  
### Social Dominance: 0.00389%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$acrv/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$acrv/time-series/social_dominance.tsv)  
Current Value: 0.00389%  
Daily Average: 0.00608%  
[--] Week: 0.00382% -0.00188%  
[--] Month: 0.0058% -0.0041%  
[--] Months: 0.0058% +0.0031%  
[--] Year: 0.0058% +0.0044%  
1-Year High: 0.06% on 2025-09-08  
1-Year Low: 0.0001% on 2025-10-11  
  
  
### Market Dominance: 0.00005896258960587365%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$acrv/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$acrv/time-series/market_dominance.tsv)  
Current Value: 0.00005896258960587365%  
Daily Average: 0%  
1-Year High: 0.00243% on 2026-02-06  
1-Year Low: 0.00006% on 2026-02-14  
  
  
### Market Cap: $52,065,958
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$acrv/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$acrv/time-series/market_cap.tsv)  
Current Value: $52,065,958  
Daily Average: $57,372,956  
[--] Week: $50,806,908 -3.60%  
[--] Month: $51,434,855 -13%  
1-Year High: $65,950,213 on 2026-01-21  
1-Year Low: $47,332,689 on 2026-02-11

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing